Decoy Therapeutics, Inc. (DCOY)
1.22
-0.01
(-0.81%)
USD |
NASDAQ |
Oct 30, 09:32
Decoy Therapeutics Gross Profit Margin (Quarterly) : 94.02% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 94.02% |
| March 31, 2026 | |
| December 31, 2025 | |
| September 30, 2025 | |
| June 30, 2025 | |
| March 31, 2025 | |
| December 31, 2024 | |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | 0.00% |
| Date | Value |
|---|---|
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 14.36% |
| March 31, 2019 | 8.79% |
| December 31, 2018 | 13.78% |
| September 30, 2018 | 33.92% |
| June 30, 2018 | 26.72% |
| March 31, 2018 | 52.97% |
| December 31, 2017 | 53.00% |
| September 30, 2017 | 64.02% |
| June 30, 2017 | 56.69% |
| March 31, 2017 | 48.58% |
| December 31, 2016 | 55.18% |
| September 30, 2016 | 63.09% |
| June 30, 2016 | 1.60% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 90.81% |
| Alnylam Pharmaceuticals, Inc. | 75.19% |
| Anika Therapeutics, Inc. | 65.15% |
| Savara, Inc. | -- |
| Vericel Corp. | 72.82% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -412.7% |
| Return on Assets | -200.9% |
| Return on Invested Capital | -412.7% |
| Profit Margin (Quarterly) | -1.04K% |
| Operating Margin (Quarterly) | -1.06K% |
| Return on Net Operating Assets | -7.67K% |